209 related articles for article (PubMed ID: 19576518)
1. Release of [3H]D-aspartate induced by K+-stimulation is increased in the cervical spinal cord of the wobbler mouse: a model of motor neuron disease.
Bonanno G; Fumagalli E; Milanese M; Zappettini S; Mennini T
Neurochem Int; 2009 Sep; 55(5):302-6. PubMed ID: 19576518
[TBL] [Abstract][Full Text] [Related]
2. Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice.
Bigini P; Gardoni F; Barbera S; Cagnotto A; Fumagalli E; Longhi A; Corsi MM; Di Luca M; Mennini T
BMC Neurosci; 2006 Oct; 7():71. PubMed ID: 17067377
[TBL] [Abstract][Full Text] [Related]
3. Proteomic profiling of cervical and lumbar spinal cord reveals potential protective mechanisms in the wobbler mouse, a model of motor neuron degeneration.
Bastone A; Fumagalli E; Bigini P; Perini P; Bernardinello D; Cagnotto A; Mereghetti I; Curti D; Salmona M; Mennini T
J Proteome Res; 2009 Nov; 8(11):5229-40. PubMed ID: 19764823
[TBL] [Abstract][Full Text] [Related]
4. Activation of gamma-aminobutyric acid GAT-1 transporters on glutamatergic terminals of mouse spinal cord mediates glutamate release through anion channels and by transporter reversal.
Raiteri L; Stigliani S; Patti L; Usai C; Bucci G; Diaspro A; Raiteri M; Bonanno G
J Neurosci Res; 2005 May; 80(3):424-33. PubMed ID: 15789377
[TBL] [Abstract][Full Text] [Related]
5. Alterations of glutamate release in the spinal cord of mice with experimental autoimmune encephalomyelitis.
Marte A; Cavallero A; Morando S; Uccelli A; Raiteri M; Fedele E
J Neurochem; 2010 Oct; 115(2):343-52. PubMed ID: 20649849
[TBL] [Abstract][Full Text] [Related]
6. Evidence for chronic mitochondrial impairment in the cervical spinal cord of a murine model of motor neuron disease.
Santoro B; Bigini P; Levandis G; Nobile V; Biggiogera M; Botti F; Mennini T; Curti D
Neurobiol Dis; 2004 Nov; 17(2):349-57. PubMed ID: 15474372
[TBL] [Abstract][Full Text] [Related]
7. Progesterone restores retrograde labeling of cervical motoneurons in Wobbler mouse motoneuron disease.
Gonzalez Deniselle MC; Garay L; Gonzalez S; Guennoun R; Schumacher M; De Nicola AF
Exp Neurol; 2005 Oct; 195(2):518-23. PubMed ID: 16095593
[TBL] [Abstract][Full Text] [Related]
8. Lack of caspase-dependent apoptosis in spinal motor neurons of the wobbler mouse.
Bigini P; Atzori C; Fumagalli E; Cagnotto A; Barbera S; Migheli A; Mennini T
Neurosci Lett; 2007 Oct; 426(2):106-10. PubMed ID: 17890007
[TBL] [Abstract][Full Text] [Related]
9. Expression of glutamate receptor subtypes in the spinal cord of control and mnd mice, a model of motor neuron disorder.
Mennini T; Bigini P; Ravizza T; Vezzani A; Calvaresi N; Tortarolo M; Bendotti C
J Neurosci Res; 2002 Nov; 70(4):553-60. PubMed ID: 12404509
[TBL] [Abstract][Full Text] [Related]
10. Reduced branching and length of dendrites detected in cervical spinal cord motoneurons of Wobbler mouse, a model for inherited motoneuron disease.
Ma WY; Vacca-Galloway LL
J Comp Neurol; 1991 Sep; 311(2):210-22. PubMed ID: 1721631
[TBL] [Abstract][Full Text] [Related]
11. Substance P neurons sprout in the cervical spinal cord of the wobbler mouse: a model for motoneuron disease.
Vacca-Galloway LL; Steinberger CC
J Neurosci Res; 1986; 16(4):657-70. PubMed ID: 2432278
[TBL] [Abstract][Full Text] [Related]
12. GABA transporter type 1 (GAT-1) uptake inhibition reduces stimulated aspartate and glutamate release in the dorsal spinal cord in vivo via different GABAergic mechanisms.
Smith CG; Bowery NG; Whitehead KJ
Neuropharmacology; 2007 Dec; 53(8):975-81. PubMed ID: 17981306
[TBL] [Abstract][Full Text] [Related]
13. Aberrant deltaPKC activation in the spinal cord of Wobbler mouse: a model of motor neuron disease.
Dave KR; Raval AP; Purroy J; Kirkinezos IG; Moraes CT; Bradley WG; Pérez-Pinzón MA
Neurobiol Dis; 2005 Feb; 18(1):126-33. PubMed ID: 15649703
[TBL] [Abstract][Full Text] [Related]
14. L-aspartate as an amino acid neurotransmitter: mechanisms of the depolarization-induced release from cerebrocortical synaptosomes.
Cavallero A; Marte A; Fedele E
J Neurochem; 2009 Aug; 110(3):924-34. PubMed ID: 19549007
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of [(3)H]glycine release from mouse spinal cord synaptosomes selectively labeled through GLYT2 transporters.
Luccini E; Raiteri L
J Neurochem; 2007 Dec; 103(6):2439-48. PubMed ID: 17944872
[TBL] [Abstract][Full Text] [Related]
16. Glutamate transporters in the spinal cord of the wobbler mouse.
Bigini P; Bastone A; Mennini T
Neuroreport; 2001 Jul; 12(9):1815-20. PubMed ID: 11435904
[TBL] [Abstract][Full Text] [Related]
17. [The distribution of motoneuronotrophic factor 1 (MNTF1) and its receptor-like substance in the spinal cord and limb muscles of mice with motoneuron disease].
Zhou M; Wu X; Chen S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Jun; 19(3):171-8. PubMed ID: 10453487
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of [3H]L-glutamate uptake from L-glutamate-induced [3H]D-aspartate release by 3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-4-carboxylic acid and 3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-6-carboxylic acid, two conformationally constrained aspartate and glutamate analogs.
Funicello M; Conti P; De Amici M; De Micheli C; Mennini T; Gobbi M
Mol Pharmacol; 2004 Sep; 66(3):522-9. PubMed ID: 15322243
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of glutamate release elicited in rat cerebrocortical nerve endings by 'pathologically' elevated extraterminal K+ concentrations.
Raiteri L; Zappettini S; Milanese M; Fedele E; Raiteri M; Bonanno G
J Neurochem; 2007 Nov; 103(3):952-61. PubMed ID: 17662048
[TBL] [Abstract][Full Text] [Related]
20. Changes in transmitter release patterns in vitro induced by tremorgenic mycotoxins.
Bradford HF; Norris PJ; Smith CC
J Environ Pathol Toxicol Oncol; 1990; 10(1-2):17-30. PubMed ID: 1977902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
